Literature DB >> 7729873

Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.

D Sturm1, J Menzel, B Gottstein, P Kern.   

Abstract

An involvement of cellular immunity in alveolar echinococcosis is strongly suggested by the intense granulomatous infiltrations observed around the hepatic parasite lesions. However, the basis of cellular immunoregulation in patient with alveolar echinococcosis is poorly understood. The present report shows a comparative analysis of lymphoid cell function in peripheral blood mononuclear cells (PBMC) of 16 patients with alveolar echinococcosis and of healthy individuals. Our in vitro restimulation studies with crude Echinococcus multilocularis antigen demonstrated that PBMC from patients with alveolar echinococcosis were responsive to challenge with parasitic antigen as measured by lymphoid cell proliferation. In this system, we also evaluated cytokine expression at the gene and protein levels after stimulation with E. multilocularis antigen. Analysis of cytokine mRNA expression revealed distinct patterns of cytokine expression in patients and normal donors. By using reverse transcriptase PCR, we could demonstrate that the TH1 cytokine transcripts interleukin-2 (IL-2) and gamma interferon (IFN-gamma) are present in PBMC from patients with alveolar echinococcosis. Moreover, it was found that stimulation with E. multilocularis antigen induced or enhanced the expression of the TH2 cytokine IL-3, IL-4, IL-10, and especially IL-5 mRNAs in PBMC from 13 of 16 patients with alveolar echinococcosis. Two patients who were examined after radical surgery, as well as another patient with a stable course of the disease under continuous chemotherapy, were not able to generate the same pattern of cytokine response and had no evidence of IL-5 mRNA synthesis. In contrast to the frequent expression of TH2 cytokine mRNAs observed in patients with alveolar echinococcosis, PBMC cultures from normal donors showed prominent IL-2 and IFN-gamma mRNA expression but weak IL-3, IL-4, and IL-10 mRNA expression. Most interestingly, IL-5 mRNA was substantially absent in PBMC from healthy individuals. In accordance with the mRNA studies, it was found that E. multilocularis antigen induced the secretion of large amounts of IL-5 and intermediate amounts of IFN-gamma in patients with alveolar echinococcosis, whereas large amounts of IFN-gamma and no or threshold amounts of IL-5 were detected in supernatants from healthy individuals. Collectively, the present study provides the first evidence that a TH2 immune response is gradually activated during the course of E. multilocularis infection, indicating a critical role for IL-5 in the manifestation of human alveolar echinococcosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729873      PMCID: PMC173211          DOI: 10.1128/iai.63.5.1688-1697.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Echinococcus multilocularis: cell-mediated immune response in early and chronic alveolar murine hydatidosis.

Authors:  Z Ali-Khan
Journal:  Exp Parasitol       Date:  1978-12       Impact factor: 2.011

4.  Humoral and cellular immunity in patients with hepatic alveolar echinococcosis. A 2 year follow-up with and without flubendazole treatment.

Authors:  D A Vuitton; A Lasségue; J P Miguet; P Hervé; T Barale; E Seillés; A Capron
Journal:  Parasite Immunol       Date:  1984-07       Impact factor: 2.280

5.  Alveolar hydatid disease. A review of clinical features of 33 indigenous cases of Echinococcus multilocularis infection in Alaskan Eskimos.

Authors:  J F Wilson; R L Rausch
Journal:  Am J Trop Med Hyg       Date:  1980-11       Impact factor: 2.345

6.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

7.  Serological differentiation between Echinococcus granulosus and E. multilocularis infections in man.

Authors:  B Gottstein; J Eckert; H Fey
Journal:  Z Parasitenkd       Date:  1983

8.  Determination of parasite-specific immunoglobulins using the ELISA in patients with echinococcosis treated with mebendazole.

Authors:  B Gottstein; J Eckert; W Woodtli
Journal:  Z Parasitenkd       Date:  1984

9.  Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57B1/6J) or 'resistant' (C57B1/10) to secondary alveolar echinococcosis.

Authors:  B Gottstein; E Wunderlin; I Tanner
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

10.  Experimental alveolar echinococcosis. Suitability of a murine model of intrahepatic infection by Echinococcus multilocularis for immunological studies.

Authors:  M Liance; D A Vuitton; S Guerret-Stocker; J P Carbillet; J A Grimaud; R Houin
Journal:  Experientia       Date:  1984-12-15
View more
  19 in total

1.  Differential expressions of MHC-DQB1 mRNA in Chinese merino sheep infected with Echinococosus granuclosus.

Authors:  Wen-Qiao Hui; Bin Jia; Zong-Sheng Zhao; Ying-Chun Du; Hong Shen
Journal:  Parasitol Res       Date:  2011-12-02       Impact factor: 2.289

2.  Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients.

Authors:  M P Hübner; B J Manfras; M C Margos; D Eiffler; W H Hoffmann; H Schulz-Key; P Kern; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

4.  Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis.

Authors:  R Riganò; E Profumo; B Buttari; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

5.  Major carbohydrate antigen of Echinococcus multilocularis induces an immunoglobulin G response independent of alphabeta+ CD4+ T cells.

Authors:  W J Dai; A Hemphill; A Waldvogel; K Ingold; P Deplazes; H Mossmann; B Gottstein
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 6.  Hepatic echinococcosis: clinical and therapeutic aspects.

Authors:  Giuseppe Nunnari; Marilia R Pinzone; Salvatore Gruttadauria; Benedetto M Celesia; Giordano Madeddu; Giulia Malaguarnera; Piero Pavone; Alessandro Cappellani; Bruno Cacopardo
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

Review 7.  Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay.

Authors:  Dominique Angèle Vuitton; Bruno Gottstein
Journal:  J Biomed Biotechnol       Date:  2010-03-21

8.  Immunomodulative effect of glucan and/or glucan supplemented with zinc in albendazole therapy for murine alveolar echinococcosis.

Authors:  Jarmila Porubcová; Emília Dvoroznáková; Zuzana Sevcíková
Journal:  Parasitol Res       Date:  2007-05-12       Impact factor: 2.289

9.  Imunomodulative effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) on mice with alveolar echinococcosis and treated with albendazole.

Authors:  Emília Dvoroznáková; Jarmila Porubcová; Viliam Snábel; Peter Fedorocko
Journal:  Parasitol Res       Date:  2008-06-29       Impact factor: 2.289

Review 10.  Echinococcosis and allergy.

Authors:  Dominique A Vuitton
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.